Macular degeneration responds to vitalMAX
Antioxidant and pigment supplements are thought to be ineffective for the “wet” form of AMD (although very helpful for the “dry” form), however, a customer who was diagnosed with the “wet” form last November, who then started taking vitalMAX capsules, reported in February this year, that all signs of her AMD had disappeared! Her consultant was incredulous as she had never witnessed this before…..
Age-related macular degeneration (AMD) tends to affect people over 50 resulting in loss of vision in the centre of the visual field (the macula) from damage to the retina. Macular degeneration can make it difficult or impossible to read or recognise faces, although enough peripheral vision remains to allow other activities of daily life. In the “dry” (non-exudative) form, cellular debris known as drusen accumulates behind the retina which can then become detached. In the “wet” (exudative) form, which is the more severe form, blood vessels grow behind the retina also causing it to become detached. Treatment usually consists of laser coagulation of these vessels or drugs that stop and sometimes reverse blood vessel growth. The “dry” form of advanced AMD, results from atrophy to the retinal pigment epithelial layer below the retina, which causes vision loss through loss of photoreceptors in the central part of the eye.
Neovascular or exudative AMD, the “wet” form of advanced AMD, causes vision loss due to abnormal blood vessel growth leading to blood and protein leakage below the macula and accounts for 10% or so of patients with macular degeneration. Bleeding, leaking, and scarring from these blood vessels eventually causes irreversible damage to the photoreceptors and rapid vision loss if left untreated.
Treatment options
No medical or surgical treatment is available for “dry” AMD, however experts agree that supplements with high doses of antioxidants, lutein and zeaxanthin may slow its progression and improve visual acuity. Studies with high beta-carotene on the other hand, have been associated with increased risk of AMD.
For the “wet” form, drugs that prevent the growth of new blood vessels are now being injected into the eyes on a monthly or bi-monthly basis. In the UK, ranibizumab (Lucentis) has been approved for this indication.
vitalMAX has an exceptional array of vital nutrients; amino acids, viatmins, minerals, pigment molecules (lutein, zeaxanthin, chlorophyll, carotenes and phycocyanin), and acts as a very powerful tonic for body and mind.
This wide range of natural nutrients, superior antioxidant power and concentrated pigment molecules offer valuable support for many chronic conditions. In addition vitalMAX contains a safe, gentle anti-inflammatory molecule, chlorophyll and thousands of enzymes to support good health.
